This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1999 Sep;23(1):18-20.

doi: 10.1038/12615.

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas

D Cappellen¹, C De Oliveira, D Ricol, S de Medina, J Bourdin, X Sastre-Garau, D Chopin, J P Thiery, F Radvanyi

Affiliations

Affiliation

¹ Laboratoire de Morphogenèse Cellulaire et Progression Tumorale, UMR 144, Centre National de la Recherche Scientifique, Institut Curie, Section de Recherche, 26 rue d'Ulm, 75248 Paris Cedex 05, France.

PMID: 10471491
DOI: 10.1038/12615

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas

D Cappellen et al. Nat Genet. 1999 Sep.

. 1999 Sep;23(1):18-20.

doi: 10.1038/12615.

Authors

D Cappellen¹, C De Oliveira, D Ricol, S de Medina, J Bourdin, X Sastre-Garau, D Chopin, J P Thiery, F Radvanyi

Affiliation

¹ Laboratoire de Morphogenèse Cellulaire et Progression Tumorale, UMR 144, Centre National de la Recherche Scientifique, Institut Curie, Section de Recherche, 26 rue d'Ulm, 75248 Paris Cedex 05, France.

PMID: 10471491
DOI: 10.1038/12615

No abstract available

PubMed Disclaimer

Similar articles

Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix.
Wu R, Connolly D, Ngelangel C, Bosch FX, Muñoz N, Cho KR. Wu R, et al. Oncogene. 2000 Nov 16;19(48):5543-6. doi: 10.1038/sj.onc.1203934. Oncogene. 2000. PMID: 11114733
Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.
Dunois-Lardé C, Levrel O, Brams A, Thiery JP, Radvanyi F. Dunois-Lardé C, et al. Mol Carcinog. 2005 Mar;42(3):142-9. doi: 10.1002/mc.20075. Mol Carcinog. 2005. PMID: 15690367
Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.
Gómez-Román JJ, Saenz P, Molina M, Cuevas González J, Escuredo K, Santa Cruz S, Junquera C, Simón L, Martínez A, Gutiérrez Baños JL, López-Brea M, Esparza C, Val-Bernal JF. Gómez-Román JJ, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):459-65. Clin Cancer Res. 2005. PMID: 15701828
The role of mutations and overexpression of the fibroblast growth factor receptor-3 in bladder cancer.
Wang QY, Zhao Y, Zhang R. Wang QY, et al. Minerva Med. 2015 Dec;106(6):333-7. Epub 2015 Nov 5. Minerva Med. 2015. PMID: 26542242 Review.
Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene.
Bellus GA, McIntosh I, Szabo J, Aylsworth A, Kaitila I, Francomano CA. Bellus GA, et al. Ann N Y Acad Sci. 1996 Jun 8;785:182-7. doi: 10.1111/j.1749-6632.1996.tb56257.x. Ann N Y Acad Sci. 1996. PMID: 8702125 Review. No abstract available.

See all similar articles

Cited by

The route to personalized medicine in bladder cancer: where do we stand?
Massari F, Ciccarese C, Santoni M, Brunelli M, Conti A, Modena A, Montironi R, Santini D, Cheng L, Martignoni G, Cascinu S, Tortora G. Massari F, et al. Target Oncol. 2015 Sep;10(3):325-36. doi: 10.1007/s11523-015-0357-x. Epub 2015 Jan 30. Target Oncol. 2015. PMID: 25634607 Review.
Expansion of the complex genotypic and phenotypic spectrum of FGFR2-associated neurocutaneous syndromes.
Schmidt J, Kaulfuß S, Ott H, Gaubert M, Reintjes N, Bremmer F, Dreha-Kulaczewski S, Stroebel P, Yigit G, Wollnik B. Schmidt J, et al. Hum Genet. 2024 Feb;143(2):159-168. doi: 10.1007/s00439-023-02634-1. Epub 2024 Jan 24. Hum Genet. 2024. PMID: 38265560 Free PMC article.
A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia.
Jin M, Yu Y, Qi H, Xie Y, Su N, Wang X, Tan Q, Luo F, Zhu Y, Wang Q, Du X, Xian CJ, Liu P, Huang H, Shen Y, Deng CX, Chen D, Chen L. Jin M, et al. Hum Mol Genet. 2012 Dec 15;21(26):5443-55. doi: 10.1093/hmg/dds390. Epub 2012 Sep 26. Hum Mol Genet. 2012. PMID: 23014564 Free PMC article.
Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.
Ferguson HR, Smith MP, Francavilla C. Ferguson HR, et al. Cells. 2021 May 14;10(5):1201. doi: 10.3390/cells10051201. Cells. 2021. PMID: 34068954 Free PMC article. Review.
Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.
van Tilborg AA, Kompier LC, Lurkin I, Poort R, El Bouazzaoui S, van der Keur K, Zuiverloon T, Dyrskjot L, Orntoft TF, Roobol MJ, Zwarthoff EC. van Tilborg AA, et al. PLoS One. 2012;7(8):e43345. doi: 10.1371/journal.pone.0043345. Epub 2012 Aug 22. PLoS One. 2012. PMID: 22927958 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information
Molecular Biology Databases
- GlyGen glycoinformatics resource
- The Weizmann Institute of Science GeneCards and MalaCards databases